Reviews: Zotarolimus stent shows efficacy in diabetes patients

04/22/2013 | Healio

Resolute Integrity's zotarolimus-eluting stent helped reduce target vessel failure rate and proved safe and effective in patients with diabetes, an analysis revealed. Another review showed insulin-treated diabetes patients had higher target lesion failure rates than non–insulin-treated diabetes patients. The results appear in JACC: Cardiovascular Interventions.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX